Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which ...

Abbott announced today that the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.

PHILADELPHIA -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000, and many patients are in the hospital again and again. But a tiny device is ...

PHILADELPHIA (WPVI) -- Heart failure is a major, and costly, medical problem. The mean cost for one hospital stay is $15,000 and many patients are in the hospital again and again. But a tiny device is ...

Last year during the holidays, R.G. Carver was using a string trimmer to knock down some weeds in his yard when he got into some cactus and got a few needles stuck in his leg. After a few days, his ...

As Abbott seeks an expanded indication for its CardioMEMS device for patients with heart failure, it’s also hoping to win over a national coverage decision from the Centers for Medicare and Medicaid ...

In the first randomized clinical trial of remote pulmonary artery pressure–guided monitoring and management of chronic heart failure (HF) in Europe, the intervention "substantially" improved quality ...

The Food and Drug Administration awarded approval to CardioMEMS Hero, a new version of the device that patients use to take daily pulmonary artery pressure readings. Abbott has made Hero smaller and ...

CardioMEMS ran into a regulatory roadblock last week, when an FDA advisory panel recommended that the agency not approve the company's Champion HF Monitoring System. The device is said to be the first ...

When Phyllis Brooks came to a local hospital due to shortness of breath, she was transferred to McLaren Greater Lansing Hospital, where further testing confirmed her diagnosis of a heart condition, ...